agilon health, inc. (AGL): Capital Expenditures

Annual figures by period end, from SEC filings.

$13.24M
Year ended 2025-12-31
$12.69M
Trailing 12 months to 2026-06-30
-5.0%
3-year compound annual growth
+49.5%
5-year compound annual growth
$15.83M2019-12-31: $2.89M2020-12-31: $1.77M2021-12-31: $6.56M2022-12-31: $15.43M2023-12-31: $15.83M2024-12-31: $13.25M2025-12-31: $13.24M$13.24M
2019-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$13.24M-0.1%2026-02-25, From 2025-01-01
2024-12-31$13.25M-16.3%2026-02-25, From 2024-01-01
2023-12-31$15.83M+2.6%2026-02-25, From 2023-01-01
2022-12-31$15.43M+135.0%2025-02-25, From 2022-01-01
2021-12-31$6.56M+269.8%2024-02-27, From 2021-01-01
2020-12-31$1.77M-38.6%2023-03-01, From 2020-01-01
2019-12-31$2.89Mn/a2022-03-03, From 2019-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
agilon health, inc. (AGL)2025-12-31$13.24M-0.1%
DaVita Inc. (DVA)2025-12-31$575.86M+3.7%
Progyny, Inc. (PGNY)2025-12-31$18.41M+240.6%
Sotera Health Co (SHC)2025-12-31$138.02M-22.9%
Viemed Healthcare, Inc. (VMD)2025-12-31$39.98M+5.9%
Cryo Cell International Inc (CCEL)2025-11-30$230.5K-90.4%
Pacific Health Care Organization Inc (PFHO)2025-12-31$23.3K+154.9%
Charming Medical Ltd (MCTA)2026-03-31$339.6K+18.1%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$116.1K+9.3%

Compare AGL, DVA, PGNY, SHC side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗